Indobufen, a new inhibitor of platelet aggregation. Studies in guinea pigs.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D001800:Blood Specimen Collection; D004176:Dipyridamole / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology; D054833:Isoindoles; D010654:Phenylbutyrates / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000502:physiology; D011517:Prothrombin Time; D012701:Serotonin / Q000378:metabolism; D013917:Thrombin / Q000502:physiology; D013928:Thromboxane A2 / Q000494:pharmacology; D013997:Time Factors
D007211:Indoles; D054833:Isoindoles; D010654:Phenylbutyrates; D011453:Prostaglandins; D012701:Serotonin; D013928:Thromboxane A2; D004176:Dipyridamole; C020371:indobufen; D013917:Thrombin; D001241:Aspirin; D007213:Indomethacin